E. Zorn et T. Hercend, A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation, EUR J IMMUN, 29(2), 1999, pp. 592-601
We have studied a case of human primary melanoma displaying the classical s
igns of a spontaneous regression in order to characterize potentially effic
ient anti-tumor T cell responses. in a previous series of experiments a uni
que TCR V beta 16(+) T cell was shown to be highly expanded at the tumor si
te. The corresponding clone was isolated in vitro and found to be a CD8(+)
cytotoxic T lymphocyte with a strong and selective cytolytic activity again
st the autologous tumor cell line. Here, we demonstrate that this predomina
nt V beta 16(+) tumorinfiltrating lymphocyte recognizes a peptide encoded b
y a novel unconventional myosin class I gene. This peptide includes a mutat
ion due to a single nucleotide substitution. The resulting Glu-->Lys replac
ement at position 911 of the coding sequence is critical to generate the re
cognized T cell epitope. These experiments demonstrate the existence of a n
atural tumor-specific cytolytic T cell response in a primary regressing hum
an melanoma lesion.